Advertisement
Screener

SI-BONE, INC. (SIBN) Operating Income

SI-BONE, INC. Operating Income

SI-BONE, INC. (SIBN) reported Operating Income of -$4.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-04

  • SI-BONE, INC. operating income (loss) for the quarter ending 2026-06-30 was -$4.81M.
  • SI-BONE, INC. operating income (loss) for the quarter ending 2026-03-31 was -$5.09M.
  • SI-BONE, INC. operating income (loss) for the quarter ending 2025-12-31 was -$2.46M.
  • SI-BONE, INC. operating income (loss) for the quarter ending 2025-09-30 was -$5.38M.
  • SI-BONE, INC. operating income (loss) for fiscal 2025 was -$22.33M.
  • SI-BONE, INC. operating income (loss) for fiscal 2024 was -$35.25M.
  • SI-BONE, INC. operating income (loss) for fiscal 2023 was -$46.93M.
  • SI-BONE, INC. operating income (loss) for fiscal 2022 was -$59.61M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$4.81M
10-Q · filed 2026-08-04
-$9.90M
10-Q · filed 2026-08-04
-$12.36M
derived: sum of 3 quarters · filed 2026-08-04
-$17.75M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$5.09M
10-Q · filed 2026-05-11
-$7.56M
derived: sum of 2 quarters · filed 2026-05-11
-$12.94M
derived: sum of 3 quarters · filed 2026-05-11
-$19.94M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$2.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$7.85M
derived: sum of 2 quarters · filed 2026-02-24
-$14.85M
derived: sum of 3 quarters · filed 2026-08-04
-$22.33M
10-K · filed 2026-02-24
2025-09-30-$5.38M
10-Q · filed 2025-11-10
-$12.39M
derived: sum of 2 quarters · filed 2026-08-04
-$19.87M
10-Q · filed 2025-11-10
-$25.36M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$7.00M
10-Q · filed 2026-08-04
-$14.48M
10-Q · filed 2026-08-04
-$19.98M
derived: sum of 3 quarters · filed 2026-08-04
-$27.61M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$7.48M
10-Q · filed 2026-05-11
-$12.97M
derived: sum of 2 quarters · filed 2026-05-11
-$20.61M
derived: sum of 3 quarters · filed 2026-05-11
-$30.68M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$5.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$13.13M
derived: sum of 2 quarters · filed 2026-02-24
-$23.20M
derived: sum of 3 quarters · filed 2026-02-24
-$35.25M
10-K · filed 2026-02-24
2024-09-30-$7.63M
10-Q · filed 2025-11-10
-$17.71M
derived: sum of 2 quarters · filed 2025-11-10
-$29.75M
10-Q · filed 2025-11-10
-$42.26M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$10.08M
10-Q · filed 2025-08-05
-$22.12M
10-Q · filed 2025-08-05
-$34.63M
derived: sum of 3 quarters · filed 2026-02-24
-$45.80M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$12.04M
10-Q · filed 2025-05-06
-$24.55M
derived: sum of 2 quarters · filed 2026-02-24
-$35.72M
derived: sum of 3 quarters · filed 2026-02-24
-$47.68M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$12.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$23.68M
derived: sum of 2 quarters · filed 2026-02-24
-$35.64M
derived: sum of 3 quarters · filed 2026-02-24
-$46.93M
10-K · filed 2026-02-24
2023-09-30-$11.17M
10-Q · filed 2024-11-12
-$23.13M
derived: sum of 2 quarters · filed 2024-11-12
-$34.42M
10-Q · filed 2024-11-12
-$45.72M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30-$11.96M
10-Q · filed 2024-08-06
-$23.26M
10-Q · filed 2024-08-06
-$34.55M
derived: sum of 3 quarters · filed 2025-02-25
-$48.12M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$11.29M
10-Q · filed 2024-05-07
-$22.59M
derived: sum of 2 quarters · filed 2025-02-25
-$36.15M
derived: sum of 3 quarters · filed 2025-02-25
-$54.03M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$11.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$24.86M
derived: sum of 2 quarters · filed 2025-02-25
-$42.74M
derived: sum of 3 quarters · filed 2025-02-25
-$59.61M
10-K · filed 2025-02-25
2022-09-30-$13.57M
10-Q · filed 2023-11-07
-$31.45M
derived: sum of 2 quarters · filed 2023-11-07
-$48.31M
10-Q · filed 2023-11-07
-$62.25M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$17.88M
10-Q · filed 2023-08-08
-$34.75M
10-Q · filed 2023-08-08
-$48.68M
derived: sum of 3 quarters · filed 2023-08-08
-$61.88M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$16.87M
10-Q · filed 2023-05-02
-$30.80M
derived: sum of 2 quarters · filed 2023-05-02
-$44.00M
derived: sum of 3 quarters · filed 2023-05-02
-$56.96M
derived: sum of 4 quarters · filed 2023-05-02
2021-12-31-$13.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
-$27.13M
derived: sum of 2 quarters · filed 2023-03-02
-$40.09M
derived: sum of 3 quarters · filed 2023-03-02
-$51.67M
10-K · filed 2023-03-02
2021-09-30-$13.20M
10-Q · filed 2022-11-08
-$26.16M
derived: sum of 2 quarters · filed 2022-11-08
-$37.74M
10-Q · filed 2022-11-08
-$45.61M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$12.96M
10-Q · filed 2022-08-09
-$24.54M
10-Q · filed 2022-08-09
-$32.41M
derived: sum of 3 quarters · filed 2022-08-09
-$41.09M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$11.57M
10-Q · filed 2022-05-10
-$19.45M
derived: sum of 2 quarters · filed 2022-05-10
-$28.12M
derived: sum of 3 quarters · filed 2022-05-10
-$38.26M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$7.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$16.55M
derived: sum of 2 quarters · filed 2022-03-01
-$26.68M
derived: sum of 3 quarters · filed 2022-03-01
-$38.57M
10-K · filed 2022-03-01
2020-09-30-$8.68M
10-Q · filed 2021-11-09
-$18.81M
derived: sum of 2 quarters · filed 2021-11-09
-$30.70M
10-Q · filed 2021-11-09
-$39.18M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$10.14M
10-Q · filed 2021-08-04
-$22.02M
10-Q · filed 2021-08-04
-$30.51M
derived: sum of 3 quarters · filed 2021-08-04
-$41.09M
derived: sum of 4 quarters · filed 2021-08-04
2020-03-31-$11.88M
10-Q · filed 2021-05-04
-$20.37M
derived: sum of 2 quarters · filed 2021-05-04
-$30.95M
derived: sum of 3 quarters · filed 2021-05-04
-$39.09M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31-$8.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
-$19.07M
derived: sum of 2 quarters · filed 2021-03-10
-$27.20M
derived: sum of 3 quarters · filed 2021-03-10
-$36.00M
10-K · filed 2021-03-10
2019-09-30-$10.58M
10-Q · filed 2020-11-03
-$18.72M
derived: sum of 2 quarters · filed 2020-11-03
-$27.52M
10-Q · filed 2020-11-03
-$31.82M
derived: sum of 4 quarters · filed 2020-11-03
2019-06-30-$8.14M
10-Q · filed 2020-08-04
-$16.94M
10-Q · filed 2020-08-04
-$21.24M
derived: sum of 3 quarters · filed 2020-08-04
-$24.29M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31-$8.80M
10-Q · filed 2020-05-05
-$13.11M
derived: sum of 2 quarters · filed 2020-05-05
-$16.15M
derived: sum of 3 quarters · filed 2020-05-05
-$17.85M
derived: sum of 4 quarters · filed 2020-05-05
2018-12-31-$4.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
-$7.35M
derived: sum of 2 quarters · filed 2020-03-11
-$9.05M
derived: sum of 3 quarters · filed 2020-03-11
-$11.96M
10-K · filed 2020-03-11
2018-09-30-$3.04M
10-Q · filed 2019-11-12
-$4.74M
derived: sum of 2 quarters · filed 2019-11-12
-$7.66M
10-Q · filed 2019-11-12
-$9.30M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$1.70M
10-Q · filed 2019-08-07
-$4.61M
10-Q · filed 2019-08-07
-$6.25M
derived: sum of 3 quarters · filed 2019-08-07
-$11.29M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$2.92M
10-Q · filed 2019-05-09
-$4.56M
derived: sum of 2 quarters · filed 2019-05-09
-$9.60M
derived: sum of 3 quarters · filed 2019-05-09
2017-12-31-$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
-$6.68M
derived: sum of 2 quarters · filed 2019-03-14
-$17.35M
10-K · filed 2019-03-14
2017-09-30-$5.04M
10-Q · filed 2018-11-29
-$15.71M
10-Q · filed 2018-11-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
SpyGlass Pharma, Inc. (SGP)United States$0.925B
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
IRADIMED CORP (IRMD)United States$1.089B52.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33